Decreased Postoperative Emesis and Opioid Use After Implementation of ERAS Protocol for Free Flap Surgery
Otolaryngology–Head and Neck Surgery · 2025
DOI: 10.1002/ohn.1043 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Otolaryngology–Head and Neck Surgery, 2025. Verfasst von Jesse K Siegel und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Loyola University Medical Center, Maywood, Illinois, USA. Hauptthemen laut MEDLINE: Free Tissue Flaps, Analgesics, Opioid, Enhanced Recovery After Surgery, Postoperative Nausea and Vomiting. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 15 Literaturangaben.
Abstract (Originalsprache)
Objective
Enhanced recovery after surgery (ERAS) protocols are designed to improve postoperative outcomes. In this study, we compare outcomes for patients undergoing head and neck free flap surgery at a quaternary care institution before and after an ERAS protocol was implemented. Study Design Retrospective study.
Setting
Single quaternary care center.
Methods
Retrospective evaluation of outcomes from patients who underwent head and neck surgery with free flap reconstruction prior to ERAS (January 2018 to May 2022, baseline) with patient outcomes after implementation (June 2022 to September 2023, ERAS). Outcomes studied included length of stay (LOS), opioid utilization, postoperative emesis, readmission, and mortality.
Results
Patients in the ERAS group had significantly lower opioid utilization (206.84 ± 217 morphine milligram equivalent vs 415.53 ± 431, P < .01) and significantly lower rates of postoperative emesis (1.74% vs 28.27%, P < .01). This difference in emesis remained significant in the subgroup of patients who underwent total laryngectomy. The decreases in opioid use and emesis remained significant in multivariate analyses controlling for demographic factors and surgery type. We found no significant decrease in LOS or mortality.
Conclusion
In the year after implementing an ERAS protocol for head and neck free flap surgery, we found significantly lower opioid utilization and the unique finding of lower postoperative emesis overall, including in the laryngectomy subgroup for whom emesis‐induced fistula is most impactful. No difference was noted in LOS or mortality. To our knowledge, this is the first study of an ERAS protocol for head and neck surgery to show a decrease in postoperative emesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, Loyola University Medical Center, Maywood, Illinois, USA.
- Clinical Research Office, Center for Translational Research and Education, Loyola University Chicago, Maywood, Illinois, USA.
ORCID-Profile: Jesse K Siegel, Kayeromi Gomez, Carol Bier-Laning
Zitieren
APA
Siegel, J. K., Gomez, K., & Bier-Laning, C. (2025). Decreased Postoperative Emesis and Opioid Use After Implementation of ERAS Protocol for Free Flap Surgery. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.1043
Vancouver
Siegel JK, Gomez K, Bier-Laning C. Decreased Postoperative Emesis and Opioid Use After Implementation of ERAS Protocol for Free Flap Surgery. Otolaryngology–Head and Neck Surgery. 2025. doi:10.1002/ohn.1043
BibTeX
@article{Siegel2025,
author = {Siegel, Jesse K and Gomez, Kayeromi and Bier-Laning, Carol},
title = {Decreased Postoperative Emesis and Opioid Use After Implementation of ERAS Protocol for Free Flap Surgery},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2025},
doi = {10.1002/ohn.1043}
}
EUVIMED